| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.2 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |